Evidence map›Paper›PMID 20886815›Full record

ArticleBiochemistry2010

Aminoglycoside binding to Oxytricha nova telomeric DNA.

Nihar Ranjan, Katrine F Andreasen, Sunil Kumar, David Hyde-Volpe, Dev P Arya

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. An assay for human telomeric G-quadruplex DNA binding drugs.Bioorganic & medicinal chemistry letters · 2013
    Article
  17. Article
  18. Recognition of HIV-TAR RNA using neomycin-benzimidazole conjugates.Bioorganic & medicinal chemistry letters · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nihar RanjanLaboratories of Medicinal Chemistry, Clemson University, Clemson, South Carolina 29634, United States.
Katrine F Andreasen
Sunil Kumar
David Hyde-Volpe
Dev P Arya
Clemson University · US

Funding

Development of Ets2-InhibitorsR15CA125724 · NCI · CLEMSON UNIVERSITY · PI ARYA, DEV PRIYA · 2008 to 2009
$398k
NCI NIH HHS R15 CA125724NCI NIH HHS R15CA125724
6 · The paper itself

Abstract

Telomeric DNA sequences have been at the center stage of drug design for cancer treatment in recent years. The ability of these DNA structures to form four-stranded nucleic acid structures, called G-quadruplexes, has been perceived as target for inhibiting telomerase activity vital for the longevity of cancer cells. Being highly diverse in structural forms, these G-quadruplexes are subjects of detailed studies of ligand-DNA interactions of different classes, which will pave the way for logical design of more potent ligands in future. The binding of aminoglycosides was investigated with Oxytricha nova quadruplex forming DNA sequence (GGGGTTTTGGGG)(2). Isothermal titration calorimetry (ITC) determined ligand to quadruplex binding ratio shows 1:1 neomycin:quadruplex binding with association constants (K(a)) ∼ 10(5) M(-1) while paromomycin was found to have a 2-fold weaker affinity than neomycin. The CD titration experiments with neomycin resulted in minimal changes in the CD signal. FID assays, performed to determine the minimum concentration required to displace half of the fluorescent probe bound, showed neomycin as the best of the all aminoglycosides studied for quadruplex binding. Initial NMR footprint suggests that ligand-DNA interactions occur in the wide groove of the quadruplex. Computational docking studies also indicate that aminoglycosides bind in the wide groove of the quadruplex.

Indexed as

AminoglycosidesAnimalsBase SequenceCalorimetryDNA, ProtozoanFramycetinGuanineHydrogen BondingLigandsMagnetic Resonance SpectroscopyModels, MolecularNeomycinOxytrichaParomomycinRibostamycinSpectrophotometry, UltravioletAminoglycosidesDNA, ProtozoanFramycetinGuanineLigandsneamineNeomycinParomomycinRibostamycin

Identifiers

PMID20886815
PMCPMC3641841
OpenAlexW2012997805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.